Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2005-9-16
pubmed:abstractText
Apoptotic responses in cardiomyocytes are opposed by the protein kinase Akt (protein kinase B) and thus can be suppressed by a number of growth factors and cytokines. In some cell types, Akt phosphorylates and inactivates members of the forkhead box (FOXO) family of transcription factors that are active in regulating the expression of proapoptotic cytokines and signaling intermediates. In the current study, we investigated the possibility that FOXO1 (FKHR) was expressed, regulated, and functional in cardiomyocytes. Addition of epidermal growth factor (EGF) (10 nM) to neonatal rat cardiomyocytes caused rapid phosphorylation of Akt and slower FOXO1 phosphorylation. In contrast, the alpha1-adrenergic receptor agonist phenylephrine (50 microM) did not phosphorylate Akt and caused dephosphorylation of FOXO1 acutely and increased FOXO1 expression with chronic exposure. Phenylephrine, but not EGF, caused nuclear translocation of FOXO1, a response that is associated with dephosphorylation. Overexpression of FOXO1 activated transcription of the proapoptotic cytokine, TNFalpha-related apoptosis-inducing ligand, as indicated by reporter gene activity. This response was enhanced by phenylephrine and inhibited by EGF. FOXO1 is expressed, regulated, and functionally active in cardiomyocytes and thus may contribute to apoptotic responses in heart.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0013-7227
pubmed:author
pubmed:issnType
Print
pubmed:volume
146
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4370-6
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16020479-Adrenergic alpha-Agonists, pubmed-meshheading:16020479-Animals, pubmed-meshheading:16020479-Animals, Newborn, pubmed-meshheading:16020479-Apoptosis, pubmed-meshheading:16020479-Cell Culture Techniques, pubmed-meshheading:16020479-DNA-Binding Proteins, pubmed-meshheading:16020479-Epidermal Growth Factor, pubmed-meshheading:16020479-Forkhead Transcription Factors, pubmed-meshheading:16020479-Gene Expression Regulation, pubmed-meshheading:16020479-Growth Substances, pubmed-meshheading:16020479-Heart, pubmed-meshheading:16020479-Heart Ventricles, pubmed-meshheading:16020479-Muscle Cells, pubmed-meshheading:16020479-Myocardium, pubmed-meshheading:16020479-Nerve Tissue Proteins, pubmed-meshheading:16020479-Phenylephrine, pubmed-meshheading:16020479-Phosphorylation, pubmed-meshheading:16020479-Rats, pubmed-meshheading:16020479-Rats, Sprague-Dawley
pubmed:year
2005
pubmed:articleTitle
Regulation of the proapoptotic factor FOXO1 (FKHR) in cardiomyocytes by growth factors and alpha1-adrenergic agonists.
pubmed:affiliation
Cellular Biochemistry Laboratory, Baker Heart Research Institute, PO Box 6492, St. Kilda Road Central, Melbourne 8009, Victoria, Australia.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't